Originally presented on November 7th, 2025.
PepGen presents an update on their DM program. Click here to learn more about PepGen.
Presenters include:
- James McArthur, PhD, President and Chief Executive Officer at PepGen
- Jane Larkindale, D.Phil, Vice President of Clinical Science at PepGen
- Sophia Roe, Patient Advocacy Associate at PepGen
- Johanna Hamel, MD Associate Professor of Neurology, Pathology, & Laboratory Medicine at the University of Rochester
Register once and you can join any of our 2025 Meet the DM Drug Developer webinars! Click here to find all our upcoming Meet the DM Drug Developer dates and previously recorded sessions. >>>
Questions or comments? Contact MDF at 415-800-7777 or at info@myotonic.org.
Thank you to our 2025 Community Education Webinar Series Sponsors, Avidity Biosciences and Dyne Therapeutics!
MDF Resources referenced in this video:
- Toolkits & Publications
- Support Groups
- Calendar of Events
- DM Drug Development Pipeline
- Myotonic Dystrophy Family Registry
- Ask the Expert series
- Study & Trial Resource Center
- Sign up for My Dispatch, our monthly e-newsletter!